Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
A new optional regional transport tax for businesses, introduced in France’s 2025 budget, aims to fund eco-friendly mobility projects. ...
Read More
A judge has authorised a dive to inspect the wreckage of a plane in the sea off Antibes. The plane crashed into the Mediterranean on September 11 1968...
Read More
In France, drinking water is heavily contaminated with "forever pollutants," particularly trifluoroacetic acid (TFA), as revealed by two studies from ...
Read More
The trial of the Tunisian man accused of the murder of three people in the Nice Basilica attack is continuing in Paris. Yesterday the families of the ...
Read More
Four cities in the Provence-Alpes-Côte d'Azur (PACA) region made Booking.com's 2025 list of the "most welcoming destinations in France." ...
Read More
